Pharmosa Biopharm Inc. (TPEX: 6875)
Taiwan
· Delayed Price · Currency is TWD
57.60
-1.60 (-2.70%)
Nov 21, 2024, 12:25 PM CST
Pharmosa Biopharm Revenue
Pharmosa Biopharm had revenue of 40.90M TWD in the quarter ending September 30, 2024, a decrease of -86.99%. This brings the company's revenue in the last twelve months to 50.52M, down -83.94% year-over-year. In the year 2023, Pharmosa Biopharm had annual revenue of 314.50M.
Revenue (ttm)
50.52M
Revenue Growth
-83.94%
P/S Ratio
140.93
Revenue / Employee
n/a
Employees
n/a
Market Cap
7.43B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 314.50M | - | - |
Dec 31, 2022 | - | - | - |
Dec 31, 2021 | - | - | - |
Dec 31, 2020 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition